Araştırma Makalesi
BibTex RIS Kaynak Göster

GEBE SAĞLIK ÇALIŞANLARINDA COVID-19 AŞISININ KABUL EDİLEBİLİRLİĞİ VE AŞI TEREDDÜTÜNE ETKİLİ FAKTÖRLER

Yıl 2022, Cilt: 19 Sayı: 3, 1386 - 1395, 30.09.2022
https://doi.org/10.38136/jgon.1077812

Öz

Amaç: Gebe sağlık çalışanlarında COVID-19 aşısının kabul edilebilirliğini ve aşı tereddütünün ana nedenlerini belirlemek. Gereçler ve Yöntem: 135 gebe sağlık çalışanına, COVID-19 aşısına yönelik algı ve tutumları ile aşının reddedilme nedenleri hakkında yüz yüze sorular soruldu. Katılımcılar (1) aşı olmak isteyip istemedikleri, (2) COVID-19 birimlerinde aktif olarak çalışıp çalışmadıkları ve (3) doktor veya başka bir sağlık çalışanı olup olmadıklarına göre değerlendirildi. Bulgular: Altmış altı (%48.9) katılımcı, gebelere COVID-19 aşısı önerilmesi durumunda aşı olmak istediklerini belirtti. COVID-19 birimlerinde aktif çalışan doktor ve diğer sağlık personellerinin aşı olma eğilimlerinin daha fazla olduğunu gözlemledik. COVID-19 aşısının bebeğe zararlı olacağı düşüncesi, diğer sağlık çalışanları grubunda doktorlara göre anlamlı derecede yüksekti.
Sonuç : Bu çalışma, gebe sağlık çalışanları arasında aşı kabul oranının, sağlık çalışanı olmayan gebelere göre daha yüksek olsa bile, COVID-19 hastalığının “sürü bağışıklığı” için gereken oranın altında kaldığını ortaya koymuştur. Gebe kadınlarda aşının güvenliğine ilişkin veri eksikliği, aşı olma isteğinin önündeki en önemli engeldir. Gebelerin COVID-19 aşılarının faz-3 çalışmalarına dahil edilmesiyle bu engel ortadan kaldırılabilir.

Kaynakça

  • 1. DeBolt CA, Bianco A, Limaye MA, Silverstein J, Penfield CA, Roman AS, et al. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. American journal of obstetrics and gynecology. 2021, 224.5: 510.
  • 2. Pierce-Williams RA, Burd J, Felder L, Khoury R, Bernstein PS, Avila K, et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study. American journal of obstetrics & gynecology MFM. 2020;2:100134.
  • 3. Sahin D, Tanacan A, Erol SA, Anuk AT, Yetiskin FD, Keskin HL, et al. Updated experience of a tertiary pandemic center on 533 pregnant women with COVID‐19 infection: A prospective cohort study from Turkey. International Journal of Gynecology & Obstetrics. 2021;152:328-34.
  • 4. Stafford IA, Parchem JG, Sibai BM. The coronavirus disease 2019 vaccine in pregnancy: risks, benefits, and recommendations. American Journal of Obstetrics and Gynecology. 2021.
  • 5. Beigi RH, Krubiner C, Jamieson DJ, Lyerly AD, Hughes B, Riley L, et al. The need for inclusion of pregnant women in COVID-19 vaccine trials. Vaccine. 2021;39:868.
  • 6. American College of Obstetricians and Gynecologists. Vaccinating pregnant and lactating patients against COVID-19: practice advisory—December 2020. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/vaccinating-pregnant-and-lactating-patientsagainst- covid-19. Accessed December 13, 2020.
  • 7. Society for Maternal-Fetal Medicine. Society for Maternal-Fetal Medicine (SMFM) statement: SARS-CoV-2 vaccination in pregnancy. https://www.smfm.org/publications/339-society-for-maternal-fetal-medicine-smfmstatement-sars-cov-2-vaccination-in-pregnancy. Accessed December 13, 2020.
  • 8. Centers for Disease Control and Prevention. COVID-19 Vaccination Considerations for People who are Pregnant or Breastfeeding. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html. Accessed January 13, 2021.
  • 9. Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495.
  • 10. Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes toward a potential SARS-CoV-2 vaccine: a survey of US adults. Annals of internal medicine. 2020;173:964-73.
  • 11. Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. The Lancet Regional Health-Europe. 2021;1:100012.
  • 12. Skjefte M, Ngirbabul M, Akeju O, Escudero D, Hernandez-Diaz S, Wyszynski DF, et al. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. European journal of epidemiology. 2021;36:197-211.
  • 13. Goncu Ayhan S, Oluklu D, Atalay A, Menekse Beser D, Tanacan A, Moraloglu Tekin O, et al. COVID‐19 vaccine acceptance in pregnant women. International Journal of Gynecology & Obstetrics.
  • 14. Singh S, Nair VG, Singh VV, Tiwari S, Arora D, Dey M, et al. Pregnancy-Specific Concerns and Psychological Impact of COVID-19 on Antenatal Women. Gynecology Obstetrics & Reproductive Medicine. 2021:1-6.
  • 15. Özceylan G, Toprak D, Esen ES. Vaccine rejection and hesitation in Turkey. Human vaccines & immunotherapeutics. 2020;16:1034-9.
  • 16. Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al. Preliminary findings of mrna covid-19 vaccine safety in pregnant persons. New England Journal of Medicine. 2021.
  • 17. Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. European journal of epidemiology. 2020;35:775-9.

ACCEPTABİLİTY OF COVID-19 VACCİNE AND FACTORS AFFECTİNG VACCİNE HESİTATİON İN PREGNANT HEALTH CARE WORKERS

Yıl 2022, Cilt: 19 Sayı: 3, 1386 - 1395, 30.09.2022
https://doi.org/10.38136/jgon.1077812

Öz

Aim: To determine the acceptability of the corona-virus disease 2019 (COVID-19) vaccine and the main reasons for vaccine hesitation in pregnant health care workers (HCWs). Method: 135 pregnant HCWs were questioned face-to-face about perception and attitudes towards the COVID-19 vaccine and reasons for rejection of the vaccine. Participants were evaluated according to:(1) whether they wanted to be vaccinated, (2) whether they were actively working in COVID-19 units, and (3) whether they were a doctor or other healthcare professional. Results: Sixty-six (48.9%) participants stated that they want to be vaccinated if the COVID-19 vaccine is recommended to pregnant women.We observed that active staff in COVID-19 units and doctors had more intention to be vaccinated.The thought that the COVID-19 vaccine would be harmful to the baby was significantly higher in other HCWs group than doctors. Conclusion: The present study revealed that even if the rate of vaccine acceptance among pregnant HCWs was higher than pregnant non-HCWs, it remained below the rate required for “herd immunity” for COVID-19 disease. Lack of data on the safety of the vaccine in pregnant women is the most important obstacle. We can overcome obstacles only by including pregnant women in phase 3 studies of COVID-19 vaccines.

Kaynakça

  • 1. DeBolt CA, Bianco A, Limaye MA, Silverstein J, Penfield CA, Roman AS, et al. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. American journal of obstetrics and gynecology. 2021, 224.5: 510.
  • 2. Pierce-Williams RA, Burd J, Felder L, Khoury R, Bernstein PS, Avila K, et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study. American journal of obstetrics & gynecology MFM. 2020;2:100134.
  • 3. Sahin D, Tanacan A, Erol SA, Anuk AT, Yetiskin FD, Keskin HL, et al. Updated experience of a tertiary pandemic center on 533 pregnant women with COVID‐19 infection: A prospective cohort study from Turkey. International Journal of Gynecology & Obstetrics. 2021;152:328-34.
  • 4. Stafford IA, Parchem JG, Sibai BM. The coronavirus disease 2019 vaccine in pregnancy: risks, benefits, and recommendations. American Journal of Obstetrics and Gynecology. 2021.
  • 5. Beigi RH, Krubiner C, Jamieson DJ, Lyerly AD, Hughes B, Riley L, et al. The need for inclusion of pregnant women in COVID-19 vaccine trials. Vaccine. 2021;39:868.
  • 6. American College of Obstetricians and Gynecologists. Vaccinating pregnant and lactating patients against COVID-19: practice advisory—December 2020. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/vaccinating-pregnant-and-lactating-patientsagainst- covid-19. Accessed December 13, 2020.
  • 7. Society for Maternal-Fetal Medicine. Society for Maternal-Fetal Medicine (SMFM) statement: SARS-CoV-2 vaccination in pregnancy. https://www.smfm.org/publications/339-society-for-maternal-fetal-medicine-smfmstatement-sars-cov-2-vaccination-in-pregnancy. Accessed December 13, 2020.
  • 8. Centers for Disease Control and Prevention. COVID-19 Vaccination Considerations for People who are Pregnant or Breastfeeding. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html. Accessed January 13, 2021.
  • 9. Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495.
  • 10. Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes toward a potential SARS-CoV-2 vaccine: a survey of US adults. Annals of internal medicine. 2020;173:964-73.
  • 11. Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. The Lancet Regional Health-Europe. 2021;1:100012.
  • 12. Skjefte M, Ngirbabul M, Akeju O, Escudero D, Hernandez-Diaz S, Wyszynski DF, et al. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. European journal of epidemiology. 2021;36:197-211.
  • 13. Goncu Ayhan S, Oluklu D, Atalay A, Menekse Beser D, Tanacan A, Moraloglu Tekin O, et al. COVID‐19 vaccine acceptance in pregnant women. International Journal of Gynecology & Obstetrics.
  • 14. Singh S, Nair VG, Singh VV, Tiwari S, Arora D, Dey M, et al. Pregnancy-Specific Concerns and Psychological Impact of COVID-19 on Antenatal Women. Gynecology Obstetrics & Reproductive Medicine. 2021:1-6.
  • 15. Özceylan G, Toprak D, Esen ES. Vaccine rejection and hesitation in Turkey. Human vaccines & immunotherapeutics. 2020;16:1034-9.
  • 16. Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al. Preliminary findings of mrna covid-19 vaccine safety in pregnant persons. New England Journal of Medicine. 2021.
  • 17. Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. European journal of epidemiology. 2020;35:775-9.
Toplam 17 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Kadın Hastalıkları ve Doğum
Bölüm Research Article
Yazarlar

Eda Ozden Tokalıoglu 0000-0003-4901-0544

Şule Göncü Ayhan 0000-0002-5770-7555

Deniz Oluklu 0000-0002-9050-2041

Muradiye Yıldırım 0000-0002-6583-2153

Özlem Moraloğlu Tekin 0000-0001-8167-3837

Dilek Sahin 0000-0001-8567-9048

Yayımlanma Tarihi 30 Eylül 2022
Gönderilme Tarihi 24 Şubat 2022
Kabul Tarihi 5 Temmuz 2022
Yayımlandığı Sayı Yıl 2022 Cilt: 19 Sayı: 3

Kaynak Göster

Vancouver Ozden Tokalıoglu E, Göncü Ayhan Ş, Oluklu D, Yıldırım M, Moraloğlu Tekin Ö, Sahin D. ACCEPTABİLİTY OF COVID-19 VACCİNE AND FACTORS AFFECTİNG VACCİNE HESİTATİON İN PREGNANT HEALTH CARE WORKERS. JGON. 2022;19(3):1386-95.